-+ 0.00%
-+ 0.00%
-+ 0.00%

GYRE THERAPEUTICS INC - F230 NDA SUBMISSION TO NMPA PLANNED FOR Q3 2025

Reuters·06/10/2025 11:00:00

Please log in to view news